Abstract
The everlasting interest in precision medicine has instigated a need for patient-specific multidimensional data collection. By leveraging consumer-level wearable devices and applications we can support this need by collecting multimodal data in uncontrolled free-living conditions. We used a continuous glucose monitor, a smartwatch with in-house developed application, and a smartphone application over a period of 14 days to collect data from 60 participants with diabetes. Data were collected on 77,683 CGM measurements, 4,073 moods, 3,517 meals, 1,394 insulin injections, and 1,364 bouts of physical activity. Participants were able to effectively use the devices and applications, with 45 participants reporting data on all modalities and all participants reporting data on at least two modalities (in addition to the data collected from the smartwatch’s internal sensors). These findings highlight the efficiency and effectiveness of consumer-level wearable devices to collect data from the comfort of the people’s homes. Thereby, facilitating the need for a cost-effective and scalable approach for precision monitoring to the public.
Competing Interest Statement
H.H. was a shareholder and on the board of directors of HRH Diabetes Games B.V. at the time this work was conducted. All other authors declare no conflict of interest.
Funding Statement
This research is part of the DiaGame project funded by NWO Data2Person (628.011.027).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Medical Research Ethics Committee of Maxima MC (nr. L20.102) gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵* Shared first-author
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
